Growth Metrics

Neogenomics (NEO) Current Deferred Tax Assets (2016)

Neogenomics filings provide 4 years of Current Deferred Tax Assets readings, the most recent being $1.2 million for Q4 2016.

  • On a quarterly basis, Current Deferred Tax Assets fell 92.51% to $1.2 million in Q4 2016 year-over-year; TTM through Dec 2016 was $1.2 million, a 92.51% decrease, with the full-year FY2016 number at $1.2 million, down 92.51% from a year prior.
  • Current Deferred Tax Assets hit $1.2 million in Q4 2016 for Neogenomics, down from $8.5 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $16.7 million in Q4 2015 to a low of $588000.0 in Q4 2013.
  • Median Current Deferred Tax Assets over the past 4 years was $821000.0 (2014), compared with a mean of $4.4 million.
  • Biggest five-year swings in Current Deferred Tax Assets: soared 1930.21% in 2015 and later crashed 92.51% in 2016.
  • Neogenomics' Current Deferred Tax Assets stood at $588000.0 in 2013, then surged by 39.63% to $821000.0 in 2014, then soared by 1930.21% to $16.7 million in 2015, then crashed by 92.51% to $1.2 million in 2016.
  • The last three reported values for Current Deferred Tax Assets were $1.2 million (Q4 2016), $8.5 million (Q3 2016), and $8.5 million (Q2 2016) per Business Quant data.